Rong Le

Array ( [id] => 7501832 [patent_doc_number] => 20110263635 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'METHOD OF TREATING ACTINIC KERATOSIS WITH 3.75% IMIQUIMOD CREAM' [patent_app_type] => utility [patent_app_number] => 13/182433 [patent_app_country] => US [patent_app_date] => 2011-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 111 [patent_figures_cnt] => 111 [patent_no_of_words] => 79074 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263635.pdf [firstpage_image] =>[orig_patent_app_number] => 13182433 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7501832 [patent_doc_number] => 20110263635 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'METHOD OF TREATING ACTINIC KERATOSIS WITH 3.75% IMIQUIMOD CREAM' [patent_app_type] => utility [patent_app_number] => 13/182433 [patent_app_country] => US [patent_app_date] => 2011-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 111 [patent_figures_cnt] => 111 [patent_no_of_words] => 79074 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263635.pdf [firstpage_image] =>[orig_patent_app_number] => 13182433 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7501820 [patent_doc_number] => 20110263634 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'LOWER DOSAGE STRENGTH PHARMACEUTICAL COMPOSITIONS FORMULATED WITH 2.5% IMIQUIMOD' [patent_app_type] => utility [patent_app_number] => 13/179402 [patent_app_country] => US [patent_app_date] => 2011-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 112 [patent_figures_cnt] => 112 [patent_no_of_words] => 79318 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263634.pdf [firstpage_image] =>[orig_patent_app_number] => 13179402 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7720904 [patent_doc_number] => 20120010239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-12 [patent_title] => '5-CHLORO-4-HYDROXY-1-METHYL-2-OXO-N-PHENYL-1,2-DIHYDROQUINOLINE-3-CARBOXAMIDE, SALTS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/178865 [patent_app_country] => US [patent_app_date] => 2011-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4037 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20120010239.pdf [firstpage_image] =>[orig_patent_app_number] => 13178865 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7501815 [patent_doc_number] => 20110263633 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'UP TO SIX WEEKS TREATMENT REGIMEN FOR TREATING ACTINIC KERATOSES WITH PHARMACEUTICAL COMPOSITIONS FORMULATED WITH 2.5% IMIQUIMOD' [patent_app_type] => utility [patent_app_number] => 13/179336 [patent_app_country] => US [patent_app_date] => 2011-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 112 [patent_figures_cnt] => 112 [patent_no_of_words] => 79157 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263633.pdf [firstpage_image] =>[orig_patent_app_number] => 13179336 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8977366 [patent_doc_number] => 20130210796 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-15 [patent_title] => 'TETRAZOLE COMPOUNDS AS CALCIUM CHANNEL BLOCKERS' [patent_app_type] => utility [patent_app_number] => 13/808243 [patent_app_country] => US [patent_app_date] => 2011-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44873 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13808243 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7768062 [patent_doc_number] => 20120035198 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-09 [patent_title] => 'Antiviral Compounds and Methods of Using Thereof' [patent_app_type] => utility [patent_app_number] => 13/179267 [patent_app_country] => US [patent_app_date] => 2011-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 14705 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20120035198.pdf [firstpage_image] =>[orig_patent_app_number] => 13179267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8265894 [patent_doc_number] => 20120165322 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-28 [patent_title] => 'RHO KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/171696 [patent_app_country] => US [patent_app_date] => 2011-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12688 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13171696 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11521541 [patent_doc_number] => 09604926 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-03-28 [patent_title] => 'Highly selective sigma receptor radioligands' [patent_app_type] => utility [patent_app_number] => 13/151084 [patent_app_country] => US [patent_app_date] => 2011-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 18 [patent_no_of_words] => 23817 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13151084 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7580996 [patent_doc_number] => 20110294879 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'METHOD OF TREATMENT OF FRAGILE X SYNDROME, DOWN\'S SYNDROME, AUTISM AND RELATED DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/118125 [patent_app_country] => US [patent_app_date] => 2011-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19808 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294879.pdf [firstpage_image] =>[orig_patent_app_number] => 13118125 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8854289 [patent_doc_number] => 20130143964 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-06 [patent_title] => 'SYMPATHETIC INHIBITOR, AND COSMETIC COMPOSITION, FOOD, AND SUNDRY ARTICLE CONTAINING THE SAME' [patent_app_type] => utility [patent_app_number] => 13/700897 [patent_app_country] => US [patent_app_date] => 2011-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3815 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13700897 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13856295 [patent_doc_number] => 10189856 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-01-29 [patent_title] => Use of sGC stimulators, sGC activators, alone and combinations with PDE5 inhibitors for the treatment of systemic sclerosis (SSc) [patent_app_type] => utility [patent_app_number] => 13/816020 [patent_app_country] => US [patent_app_date] => 2011-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 7456 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13816020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8904794 [patent_doc_number] => 20130172297 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-04 [patent_title] => 'Treatment of Autoimmune Diseases' [patent_app_type] => utility [patent_app_number] => 13/643320 [patent_app_country] => US [patent_app_date] => 2011-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4166 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13643320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7574068 [patent_doc_number] => 20110269724 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'Combination Therapy with Non-Selective COX Inhibitors to Prevent COX-Related Gastric Injuries' [patent_app_type] => utility [patent_app_number] => 13/100204 [patent_app_country] => US [patent_app_date] => 2011-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14533 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20110269724.pdf [firstpage_image] =>[orig_patent_app_number] => 13100204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8173653 [patent_doc_number] => 20120108553 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'Combination Therapy with Non-Selective COX Inhibitors to Prevent COX-Related Gastric Injuries' [patent_app_type] => utility [patent_app_number] => 13/100205 [patent_app_country] => US [patent_app_date] => 2011-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14542 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20120108553.pdf [firstpage_image] =>[orig_patent_app_number] => 13100205 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7511513 [patent_doc_number] => 20110257223 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'Modulators of Cystic Fibrosis Transmembrane Conductance Regulator' [patent_app_type] => utility [patent_app_number] => 13/092838 [patent_app_country] => US [patent_app_date] => 2011-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36376 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20110257223.pdf [firstpage_image] =>[orig_patent_app_number] => 13092838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9074462 [patent_doc_number] => 08552040 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-08 [patent_title] => 'Isoxazoline compounds having MIF antagonist activity' [patent_app_type] => utility [patent_app_number] => 13/086939 [patent_app_country] => US [patent_app_date] => 2011-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10994 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13086939 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7511476 [patent_doc_number] => 20110257186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING VISUAL DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/085241 [patent_app_country] => US [patent_app_date] => 2011-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3140 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20110257186.pdf [firstpage_image] =>[orig_patent_app_number] => 13085241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6178207 [patent_doc_number] => 20110178178 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'Treatment of Motor Fluctuations' [patent_app_type] => utility [patent_app_number] => 13/077478 [patent_app_country] => US [patent_app_date] => 2011-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3777 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20110178178.pdf [firstpage_image] =>[orig_patent_app_number] => 13077478 [rel_patent_id] =>[rel_patent_doc_number] =>)